|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$96,000
|
N/A
|
National Institutes of Health
|
|
COG NCTN Network Group Operations Center
|
1U10CA180886-01
|
$26,616,497
|
$2,129,320
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
2P30CA008748-48
|
$12,352,942
|
$123,529
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
$101,162
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
$223,491
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
5P30CA082103-16
|
$7,049,997
|
$141,000
|
CARROLL, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Regional Oncology Research Center
|
5P30CA006973-51
|
$6,785,409
|
$67,854
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-39
|
$6,071,261
|
$728,551
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
2P30CA021765-35
|
$5,765,603
|
$115,312
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-40
|
$4,421,130
|
$88,423
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-20
|
$4,071,218
|
$407,122
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Specialized Cancer Center Support Grant
|
2P30CA023100-28
|
$3,730,476
|
$111,914
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Cancer Center Support Grant
|
2P30CA013696-40
|
$3,596,904
|
$143,876
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
National Center: Multiscale Analysis of Genomic and Cellular Networks (MAGNet)
|
5U54CA121852-10
|
$3,589,179
|
$287,134
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,301,947
|
$165,097
|
Merchant, Melinda
|
CCR (NCI)
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S7
|
$3,000,000
|
$240,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
$164,804
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-32
|
$2,459,346
|
$196,748
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-15
|
$1,925,523
|
$1,925,523
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-12
|
$1,874,319
|
$468,580
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-06
|
$1,560,000
|
$15,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S5
|
$1,543,656
|
$123,492
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)
|
3U24CA114766-08S1
|
$1,510,732
|
$302,146
|
RAMIREZ, NILSA
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Systems Biology of Tumor Progression and Drug Resistance
|
5U01CA168426-03
|
$1,165,605
|
$1,165,605
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S4
|
$1,163,256
|
$93,060
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Immunobiology and Immunotherapy of Pediatric Cancer
|
ZIA BC 011073
|
$971,233
|
$97,123
|
Mackall, Crystal
|
CCR (NCI)
|
|
Targeting Neuroblastoma with armed T cells
|
1R01CA182526-01A1
|
$802,464
|
$802,464
|
LUM, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$787,265
|
$314,906
|
Khan, Javed
|
CCR (NCI)
|
|
Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
|
1R01CA182633-01
|
$704,800
|
$704,800
|
ASGHARZADEH, SHAHAB
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways
|
2R01CA057138-23A1
|
$589,250
|
$294,625
|
EISENMAN, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Development and Execution of High-Content Imaging Assays
|
ZIC BC 011567
|
$577,428
|
$115,486
|
Pegoraro, Gianluca
|
CCR (NCI)
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$577,062
|
$346,237
|
Thiele, Carol
|
CCR (NCI)
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-07
|
$562,701
|
$562,701
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF PEDIATRIC CANCERS
|
ZIA BC 011002
|
$524,843
|
$524,843
|
Khan, Javed
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$524,012
|
$104,802
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$524,012
|
$52,401
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$483,032
|
$24,152
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-04
|
$473,452
|
$345,620
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
MYC--Transcription and Apoptosis
|
2R01CA051497-23A1
|
$456,800
|
$228,400
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Engineering and Evaluation of Human L-Methionase for Cancer Therapy
|
5R01CA154754-04
|
$414,813
|
$414,813
|
GEORGIOU, GEORGE
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
Pretherapy 124I-MIBG Dosimetry for Planning 131I-MIBG Neuroblastoma Therapy
|
5R01CA154561-04
|
$409,896
|
$409,896
|
SEO, YOUNGHO
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
2R01CA140198-06
|
$404,266
|
$404,266
|
MOSSE, YAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Quantitative SPECT for Targeted Radionuclide Therapy
|
5R01CA109234-09
|
$403,527
|
$100,882
|
FREY, ERIC
|
JOHNS HOPKINS UNIVERSITY
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
1U10CA180884-01
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$358,240
|
$32,242
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$358,240
|
$35,824
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
|
5R01CA164365-03
|
$354,947
|
$354,947
|
HSU, KATHARINE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma
|
5R01CA148688-04
|
$352,231
|
$352,231
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
Combination therapy to inhibit neuroblastoma growth
|
5R01CA147792-05
|
$344,838
|
$344,838
|
GONDI, CHRISTOPHER
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Sphingosine-1-Phosphate Pathway Based Therapy for Neuroblastoma
|
5R01CA168903-03
|
$335,040
|
$335,040
|
FERRER, FERNANDO
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
Total relevant funding to Neuroblastoma for this search: $23,581,708
|